the fact the Directors have bought in again absolutely shows that believe this hiccup will be rectified. I actually feel more comfortable now about my investment than I did before, at least the BOD now know what is on the table and what to address. I just wish that I had had the balls (and money) to buy in again last week at the low unfortunately I am heavily invested in the £1 range. I think there was a golden opportunity missed there.
I'm sure the board will be working behind the scenes to reassure the major shareholders that the questions raised in the CRL are rectifiable and hopefully stop the rot. If they can do this we may see further buying at these low prices.
RE: SP after FDA and Hatch Waxman05 Oct 2021 15:05
I think peoples immediate expectations if successfully approved are somewhat over optimistic. I think a modest rise and and then settle down again. The downside in my opinion would be far worse. I'm in for the long haul (IF approved) GLA.